Biosimilars: EMEA Wants Approvals

European regulators’ guidelines on biosimilars show that they are serious about quickly approving cheaper follow-on biologics. The hurdles may come thereafter.

By Melanie Senior

One of the industry's hottest topics, biosimilars, will be at the top of the list this fall for executives at...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from In Vivo Archive

More from In Vivo